PERKINS CAPITAL MANAGEMENT INC

Position in CATX — Perspective Therapeutics, Inc.

CIK 884300 WAYZATA, MN

Position in CATX

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$62,062

-$659,281 QoQ

Shares Held

18,200

-93.2% QoQ

Ownership

0.016%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#86

of 130 holders

Holding Since

Mar 2021

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PERKINS CAPITAL MANAGEMENT INC holds $25,978,704 across 18 Medical Devices names. CATX ranks #16 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BFLY	Butterfly Network, Inc.	867,580	$7,305,023
2	AXGN	Axogen, Inc.	147,842	$6,828,821
3	ABT	Abbott Laboratories	20,257	$1,838,120
4	NEOG	Neogen Corp	177,500	$1,595,725
5	ATEC	Alphatec Holdings, Inc.	175,197	$1,515,454
6	LUCD	Lucid Diagnostics Inc.	1,125,000	$1,203,750
7	TLSI	TriSalus Life Sciences, Inc.	235,101	$1,069,709
8	TELA	TELA Bio, Inc.	1,375,042	$1,031,281

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$62,062	18,200	-99.3%	Shares	Sole	2026-07-24
2023-09-30	$721,343	2,671,644	-0.1%	Shares	Sole	2023-11-02
2023-06-30	$1,792,011	2,674,644	-2.7%	Shares	Sole	2023-07-21
2023-03-31	$1,759,772	2,749,644	-0.8%	Shares	Sole	2023-05-09
2022-12-31	$693,161	2,772,644	-4.9%	Shares	Sole	2023-01-26
2022-06-30	$903,495	2,914,500	+87.7%	Shares	Sole	2022-07-29
2021-09-30	$978,390	1,553,000	-6.1%	Shares	Sole	2021-10-25
2021-06-30	$1,323,200	1,654,000	+18.2%	Shares	Sole	2021-07-28
2021-03-31	$1,524,910	1,399,000	—	Shares	Sole	2021-04-28
No filing history on record for this holder in this stock.